World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
72653
World Ranking
8397
National Ranking
4341

R. Michael Tuttle publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where R. Michael Tuttle sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 380 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

R. Michael Tuttle D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where R. Michael Tuttle sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

R. Michael Tuttle is affiliated with the Memorial Sloan Kettering Cancer Center in the United States and has a significant body of work within the field of medicine, particularly focusing on thyroid cancer diagnosis and treatment. Their research extends into related subfields including endocrinology, diabetes and metabolism, surgery, radiology, nuclear medicine, imaging, genetics, and oncology.

The main topics covered in their research portfolio include:

  • Thyroid Cancer Diagnosis and Treatment
  • Thyroid and Parathyroid Surgery
  • BRCA gene mutations in cancer
  • Head and Neck Anomalies
  • Radiomics and Machine Learning in Medical Imaging
  • Pituitary Gland Disorders and Treatments
  • Patient-Provider Communication in Healthcare

Some of the recent papers associated with their research include:

  • "Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases," 2020, published in Thyroid
  • "Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association," 2021, Head & Neck
  • "American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment," 2022, Head & Neck
  • "Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases," 2021, Histopathology
  • "A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid Cancer," 2021, Thyroid

Frequent co-authors contributing to research alongside R. Michael Tuttle include:

  • Ashok R. Shaha
  • Ronald Ghossein
  • Ian Ganly
  • Richard J. Wong
  • Jatin P. Shah

The primary venues for their publications reflect their concentration in specialized clinical and surgical research. These include:

  • Thyroid
  • JAMA Otolaryngology-Head & Neck Surgery
  • Annals of Surgical Oncology
  • The Journal of Clinical Endocrinology & Metabolism
  • Histopathology

Best Publications

  • 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

    Bryan R. Haugen;Erik K. Alexander;Keith C. Bible;Gerard M. Doherty

  • Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

    David S. Cooper;Gerard M. Doherty;Bryan R. Haugen;Richard T. Kloos

  • Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

    David S. Cooper;Gerard M. Doherty;Bryan R. Haugen;Richard T. Kloos

  • Integrated Genomic Characterization of Papillary Thyroid Carcinoma

    Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally

  • Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors

    Yuri E. Nikiforov;Raja R. Seethala;Giovanni Tallini;Zubair W. Baloch

  • Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

    Michael Mingzhao Xing;Ali S. Alzahrani;Kathryn A. Carson;David Viola

  • American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer

    Robert C. Smallridge;Kenneth B. Ain;Kenneth B. Ain;Sylvia L. Asa;Sylvia L. Asa;Keith C. Bible

  • Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

    Alan L. Ho;Ravinder K. Grewal;Rebecca Leboeuf;Eric J. Sherman

  • Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.

    R. Michael Tuttle;Hernan Tala;Jatin Shah;Rebecca Leboeuf

  • Consensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid Cancer

    Sally E. Carty;David S. Cooper;Gerard M. Doherty;Quan Yang Duh

  • Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning

    Richard J. Robbins;Qiang Wan;Ravinder K. Grewal;Roland Reibke

  • Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society.

    Hossein Gharib;R. Michael Tuttle;H. Jack Baskin;Lisa H. Fish

  • Mutational Profile Of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA and AKT1

    Julio C. Ricarte-Filho;Mabel Ryder;Dhananjay A. Chitale;Michael Rivera

  • Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?

    R. Michael Tuttle;Bryan Haugen;Nancy Dugal Perrier

  • Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer

    Mingzhao Xing;Ali S. Alzahrani;Kathryn A. Carson;Young Kee Shong

  • Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.

    Jeffrey Liu;Bhuvanesh Singh;Giovanni Tallini;Diane L. Carlson

  • Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance

    R. Michael Tuttle;James A. Fagin;Gerald Minkowitz;Richard J. Wong

  • Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy

    N. Gopalakrishna Iyer;Luc G. T. Morris;R. Michael Tuttle;Ashok R. Shaha

  • Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy.

    Iain J. Nixon;Ian Ganly;Snehal G. Patel;Frank L. Palmer

  • Controversies, Consensus, and Collaboration in the Use of 131 I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association

    R. Michael Tuttle;Sukhjeet Ahuja;Anca M. Avram;Victor J. Bernet

Frequent Co-Authors

Ashok R. Shaha
Ashok R. Shaha Memorial Sloan Kettering Cancer Center
Ian Ganly
Ian Ganly Memorial Sloan Kettering Cancer Center
Ronald Ghossein
Ronald Ghossein Memorial Sloan Kettering Cancer Center
Jatin P. Shah
Jatin P. Shah Memorial Sloan Kettering Cancer Center
Snehal G. Patel
Snehal G. Patel Memorial Sloan Kettering Cancer Center
James A. Fagin
James A. Fagin Memorial Sloan Kettering Cancer Center
Richard J. Wong
Richard J. Wong Memorial Sloan Kettering Cancer Center
Steven M. Larson
Steven M. Larson Memorial Sloan Kettering Cancer Center
Luc G. T. Morris
Luc G. T. Morris Memorial Sloan Kettering Cancer Center
Mithat Gonen
Mithat Gonen Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring diverse educational and career pathways is essential for students passionate about the medical field. Online programs are making it easier than ever to advance, no matter your starting point or schedule.

Registered nurses who want to earn a Bachelor of Science in Nursing might be interested in the flexibility of an rn to bsn online with no clinicals program. These are designed for working professionals and can help boost your credentials without additional on-site requirements.

For those considering a doctoral path, there are options such as the fastest online dnp programs and easy dnp programs. These Doctor of Nursing Practice degrees offer a range of timelines and workloads to fit different learning styles and career goals.

If your goal is to enter the nursing field quickly, consider an accelerated lpn program. These fast-track online offerings allow you to start your healthcare career sooner.

Each pathway caters to different backgrounds and ambitions, making medical education in the USA more accessible and flexible than ever.

Best Scientists Citing R. Michael Tuttle

Trending Scientists

Recently Published Articles